Yale University

The Impact of Enhanced Screening and Treatment on Hepatitis C in the United States.

TitleThe Impact of Enhanced Screening and Treatment on Hepatitis C in the United States.
Publication TypeJournal Article
Year of Publication2015
AuthorsDurham, David P., Laura A. Skrip, Robert Douglas Bruce, Silvia Vilarinho, Elamin H. Elbasha, Alison P. Galvani, and Jeffrey P. Townsend
JournalClinical infectious diseases : an official publication of the Infectious Diseases Society of America
Date Published2015 Nov 30
ISSN1537-6591
Abstract The effectiveness of interferon-free direct-acting antivirals (DAA) in treating chronic hepatitis C virus (HCV) is limited by low screening and treatment rates, particularly among people who inject drugs (PWIDs).
DOI10.1093/cid/civ894
Alternate JournalClin. Infect. Dis.

External Links